709 filings
Page 4 of 36
8-K
e0c6tmtpq jucavuud
12 Nov 21
Viveve Reports Third Quarter 2021 Financial Results and Provides Corporate Update
8:29am
8-K
xgjfhhcokebezadb
28 Oct 21
Issuance further expands and strengthens Company’s intellectual property portfolio
8:29am
8-K
2p0ftvw1ce yi3fuc
23 Sep 21
Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia
8:29am
8-K
qehxz
7 Sep 21
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
8:29am
8-K
5kstv7fj3
12 Aug 21
Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
5igq51 al
3 Aug 21
Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent
8:29am
UPLOAD
imkmipqli
12 Jul 21
Letter from SEC
12:00am
8-K
6qzr32akr6
7 Jul 21
Viveve Announces New Category III CPT Code for its Stress Urinary Incontinence Procedure
8:29am
8-K
q376jz 50
6 Jul 21
Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference
8:29am
S-8
rs6 nm5eojm6t
2 Jul 21
Registration of securities for employees
4:19pm
8-K
t1sj k248ml
25 Jun 21
Departure of Directors or Certain Officers
4:02pm
DEFA14A
q1qdgkbsyby 43rttoea
16 Jun 21
Additional proxy soliciting materials
7:03am
8-K
jx4g9f2b59
16 Jun 21
Amendments to Articles of Incorporation or Bylaws
7:01am
8-K
4g47ut2lrx03vge0
10 Jun 21
Issuance expands patent claims for Company’s dual-energy technology
8:29am
8-K
7r25h3e0fu9 el6z90j
2 Jun 21
Viveve Announces Adjournment of Annual Meeting
4:10pm
DEFA14A
h7rqwag3lh
2 Jun 21
Additional proxy soliciting materials
4:08pm